JP2019533434A5 - - Google Patents

Download PDF

Info

Publication number
JP2019533434A5
JP2019533434A5 JP2019513876A JP2019513876A JP2019533434A5 JP 2019533434 A5 JP2019533434 A5 JP 2019533434A5 JP 2019513876 A JP2019513876 A JP 2019513876A JP 2019513876 A JP2019513876 A JP 2019513876A JP 2019533434 A5 JP2019533434 A5 JP 2019533434A5
Authority
JP
Japan
Prior art keywords
expression cassette
cells
sequence
pharmaceutical composition
gene delivery
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019513876A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019533434A (ja
JP7197466B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/050837 external-priority patent/WO2018049273A1/en
Publication of JP2019533434A publication Critical patent/JP2019533434A/ja
Publication of JP2019533434A5 publication Critical patent/JP2019533434A5/ja
Priority to JP2022117708A priority Critical patent/JP2022160505A/ja
Application granted granted Critical
Publication of JP7197466B2 publication Critical patent/JP7197466B2/ja
Priority to JP2024228258A priority patent/JP2025043346A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019513876A 2016-09-08 2017-09-08 ファンコニ貧血患者に対する遺伝子療法 Active JP7197466B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2022117708A JP2022160505A (ja) 2016-09-08 2022-07-25 ファンコニ貧血患者に対する遺伝子療法
JP2024228258A JP2025043346A (ja) 2016-09-08 2024-12-25 ファンコニ貧血患者に対する遺伝子療法

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201662385185P 2016-09-08 2016-09-08
US62/385,185 2016-09-08
US201662412028P 2016-10-24 2016-10-24
US62/412,028 2016-10-24
PCT/US2017/050837 WO2018049273A1 (en) 2016-09-08 2017-09-08 Gene therapy for patients with fanconi anemia

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022117708A Division JP2022160505A (ja) 2016-09-08 2022-07-25 ファンコニ貧血患者に対する遺伝子療法

Publications (3)

Publication Number Publication Date
JP2019533434A JP2019533434A (ja) 2019-11-21
JP2019533434A5 true JP2019533434A5 (https=) 2020-10-08
JP7197466B2 JP7197466B2 (ja) 2022-12-27

Family

ID=61561668

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2019513876A Active JP7197466B2 (ja) 2016-09-08 2017-09-08 ファンコニ貧血患者に対する遺伝子療法
JP2022117708A Pending JP2022160505A (ja) 2016-09-08 2022-07-25 ファンコニ貧血患者に対する遺伝子療法
JP2024228258A Pending JP2025043346A (ja) 2016-09-08 2024-12-25 ファンコニ貧血患者に対する遺伝子療法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2022117708A Pending JP2022160505A (ja) 2016-09-08 2022-07-25 ファンコニ貧血患者に対する遺伝子療法
JP2024228258A Pending JP2025043346A (ja) 2016-09-08 2024-12-25 ファンコニ貧血患者に対する遺伝子療法

Country Status (11)

Country Link
US (1) US20190203225A1 (https=)
EP (1) EP3510162A4 (https=)
JP (3) JP7197466B2 (https=)
KR (2) KR20240151726A (https=)
CN (1) CN110536966A (https=)
AU (3) AU2017322511B2 (https=)
CA (1) CA3035605A1 (https=)
IL (2) IL320371A (https=)
MX (1) MX2019002699A (https=)
SG (1) SG11201901718VA (https=)
WO (1) WO2018049273A1 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE055862T2 (hu) 2016-04-20 2021-12-28 Centro De Investig Energeticas Készítmények és eljárások PKLR fokozott génexpressziójára
SG11202002263TA (en) 2017-10-16 2020-04-29 Centro De Investigaciones Energeticas Medioambientales Y Tecnologicas Lentiviral vectors for delivery of pklr to treat pyruvate kinase deficiency
WO2019200167A1 (en) * 2018-04-11 2019-10-17 Rocket Pharmaceuticals, Ltd. Compositions and methods for stem cell transplant
MX2020011386A (es) 2018-04-27 2021-01-29 Spacecraft Seven Llc Terapia genica para la degeneracion del snc.
KR102918544B1 (ko) * 2018-07-12 2026-01-27 로켓 파마슈티컬스, 리미티드 다논병을 치료하기 위한 유전자 요법 벡터
KR20210046004A (ko) * 2018-07-30 2021-04-27 센트로 데 인베스띠가씨오네스 에너제티까스 메디오암비엔딸레스 와이 테크놀로지까스, 오.에이., 엠.피. 조혈 세포의 유전자 변형 방법
CN110904102A (zh) * 2018-09-18 2020-03-24 中国科学院上海生命科学研究院 一种用于重组蛋白质表达的启动子
EP3927841A1 (en) * 2019-02-21 2021-12-29 F. Hoffmann-La Roche AG Improved nucleic acid target enrichment and related methods
SG11202112347RA (en) * 2019-05-23 2021-12-30 Spacecraft Seven Llc Gene therapy vectors for infantile malignant osteopetrosis
DE102020111571A1 (de) 2020-03-11 2021-09-16 Immatics US, Inc. Wpre-mutantenkonstrukte, zusammensetzungen und zugehörige verfahren
KR20230043869A (ko) 2020-08-07 2023-03-31 스페이스크래프트 세븐, 엘엘씨 Aav 벡터를 사용한 플라코필린-2(pkp2) 유전자 요법
AU2022264498A1 (en) * 2021-04-26 2023-09-28 Strm.Bio Incorporated Compositions and methods related to megakaryocyte-derived extracellular vesicles for fanconi anemia
US20250221931A1 (en) * 2022-03-25 2025-07-10 Modernatx, Inc. Polynucleotides encoding fanconi anemia, complementation group proteins for the treatment of fanconi anemia
WO2025137373A1 (en) * 2023-12-19 2025-06-26 Cellarity, Inc. Disease detection systems and methods

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5952190A (en) * 1996-10-04 1999-09-14 Fanconi Anemia Research Fund, Inc. cDNA for fanconi anemia complementation group A
GB0024550D0 (https=) 2000-10-06 2000-11-22 Oxford Biomedica Ltd
US20070048285A1 (en) 2005-08-24 2007-03-01 Christopher Baum Self-inactivating retroviral vector
WO2010126766A1 (en) * 2009-04-30 2010-11-04 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Inducible interleukin-12
DE102009021592A1 (de) * 2009-05-15 2010-11-18 Medizinische Hochschule Hannover ASLV-Vektorsystem
KR20140045411A (ko) 2011-05-16 2014-04-16 젠자임 코포레이션 Cxcr4 길항제의 용도
AU2013293270B2 (en) * 2012-07-25 2018-08-16 Massachusetts Institute Of Technology Inducible DNA binding proteins and genome perturbation tools and applications thereof
WO2014100073A2 (en) * 2012-12-21 2014-06-26 Merck Sharp & Dohme Corp. Expression vectors for recombinant protein production in mammalian cells
GB201318347D0 (en) 2013-10-16 2013-11-27 Ucl Business Plc Retroviral vectors
WO2015073922A2 (en) * 2013-11-15 2015-05-21 Northwestern University Inhibition of oxidative stress in atrial fibrillation
US20170037431A1 (en) 2014-05-01 2017-02-09 University Of Washington In vivo Gene Engineering with Adenoviral Vectors
WO2015188191A1 (en) * 2014-06-06 2015-12-10 Wong Wilson W Dna recombinase circuits for logical control of gene expression
WO2016118780A1 (en) 2015-01-21 2016-07-28 Fred Hutchinson Cancer Research Center Point-of-care and/or portable platform for gene therapy
WO2016183593A2 (en) * 2015-05-14 2016-11-17 The Regents Of The University Of California Prenatal therapy

Similar Documents

Publication Publication Date Title
JP2019533434A5 (https=)
IL320371A (en) Gene therapy for patients with fanconi anemia
CA3076270C (en) Retroviral vectors
CN112040988A (zh) 修饰的aav衣壳多肽用于治疗肌肉疾病
US20210222178A1 (en) MICROBIAL SYSTEM FOR PRODUCTION AND DELIVERY OF EUKARYOTE-TRANSLATABLE mRNA TO EUKARYA
JP2017505626A5 (https=)
JP2019501882A5 (https=)
JP2024521811A5 (https=)
JP2020533969A5 (https=)
JP2022514465A5 (https=)
CN112442514B (zh) 慢病毒包装载体系统、慢病毒及其构建方法、试剂盒
JP5123922B2 (ja) 融合糖タンパク質から成るエンベロープを有する逆行性輸送ウィルスベクター系
JP2021528407A5 (https=)
JP2011115077A5 (https=)
AU2021206846A1 (en) Lentivirus packaging system, method for improving lentivirus production in a host cell, and method for treating cancer
CN101532031A (zh) 非整合慢病毒载体系统及其制备与应用
US20230416777A1 (en) Moloney murine leukemia virus-based self-inactivating vector and applications thereof
JP2020517289A5 (https=)
CN116555351B (zh) 一种核酸构建体
CN117866107A (zh) 靶向cd5分子的嵌合抗原受体t细胞及其抗肿瘤应用
RU2023119872A (ru) Генная терапия пациентов с анемией фанкони
CN121342932B (zh) 许氏平鲉内源性逆转录病毒包膜蛋白P_env、慢病毒载体及其应用
CN115197969A (zh) 一种治疗乙型肝炎的慢病毒载体、慢病毒颗粒及其制备方法和应用
JP2012110290A5 (https=)
JP2024516115A5 (https=)